Research articleSimultaneous quantification of gatifloxacin, moxifloxacin, and besifloxacin concentrations in cornea and aqueous humor by LC-QTOF/MS after topical ocular dosing
Introduction
Fluoroquinolones are antimicrobial drugs used worldwide for the treatment of infections in humans and animals. The pharmacological mechanism of action of fluoroquinolones involves binding to topoisomerase IV and gyrase in the presence of DNA, causing changes in the conformation of the formed protein. Quinolones are bacteriostatic agents because they prevent bacteria replication (Cheng et al., 2013, Aldred et al., 2014, Tse-Dinh, 2015). The fourth-generation quinolones are products of chemical modifications resulting in an extension of the antimicrobial spectrum of former generations to broad-spectrum activity covering gram-negative and gram-positive bacteria. These compounds are widely used for the prophylaxis and treatment of ocular infection (Mather et al., 2002, Scoper, 2008).
Fourth-generation fluoroquinolone ophthalmic solutions include gatifloxacin, moxifloxacin (McGee, Holt, Kastner, & Rice, 2005), and besifloxacin (Deschênes and Blondeau, 2015, Gu et al., 2016a). The ophthalmic suspension of besifloxacin, a more recent fluoroquinolone developed exclusively for ophthalmic use, contains a mucoadhesive polymer (Deschênes and Blondeau, 2015, Gu et al., 2016a, Chung et al., 2013) that may contribute towards its ability to maintain concentrations in both cornea and aqueous humor, perhaps by reducing elimination due to lacrimation.
For effective therapeutic action, these drugs must be present in certain concentrations at the target tissue. Intraocular penetration of the drug is hampered by defense mechanisms protecting the eyes – the two most important being the corneal barrier affecting drug permeability and lacrimal drainage of the drug (Samuelson, 2013, Nautscher et al., 2015). Drugs with high intraocular penetration and those that maintain adequate intraocular concentrations are considered the most effective topical ocular antimicrobials (Chung et al., 2013, Maggs, 2008).
Reported methods for measuring fluoroquinolones in ocular samples are high-performance liquid chromatography with fluorescence detection (FLD) (Basci et al., 1997, Davis et al., 2010, Matsuura et al., 2013) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) (Gu et al., 2016b, Proksch et al., 2009). Methods for measurement in plasma also include high-performance liquid chromatography with ultraviolet detection (HPLC-UV) (Cavazos-Rocha, Carmona-Alvarado, Vera-Cabrera, Waksman-de-Torres, & Salazar-Cavazos, 2014). To the best of our knowledge, liquid chromatography (LC) coupled to quadrupole time-of-flight mass spectrometry (QTOF/MS) has not been reported for determination of fluoroquinolones in ocular samples.
The aim of this study was to develop and validate an analytical method for the detection and quantification of gatifloxacin, moxifloxacin, and besifloxacin concentrations in cornea and aqueous humor by a LC-QTOF/MS employing QuanTOF technology. Another aim was to determine the concentrations of these antimicrobials in the cornea and aqueous humor of dogs, 10 min and 1 h after instillation of these topical ophthalmic suspensions.
Section snippets
Reagents and standard solutions
Gatifloxacin sesquihydrate and moxifloxacin hydrochloride were obtained from Fluka - Sigma-Aldrich (St. Louis, MO, USA), and besifloxacin hydrochloride was acquired from Santa Cruz Biotechnology (Santa Cruz, CA, USA). LC-MS-grade methanol was purchased from Baker (Xalostoc, México), and formic acid was purchased from Tedia (Ohio, USA).
The standard stock solution was prepared in methanol:water (4:1) at a concentration of 1000 μg/mL and stored at − 20 °C. The working standard solutions were prepared
Method development and assay validation
Typical chromatograms of cornea samples spiked with the three antimicrobials and blank samples are shown in Fig. 1. The retention times were approximately 1.42 min for gatifloxacin, 1.87 min for moxifloxacin, and 3.01 min for besifloxacin. No interference peak was detected for the three tested antimicrobials in both cornea and aqueous humor samples, ensuring that the peak response was attributable only to the antimicrobial of interest. The calibration curves were linear for the three tested
Conclusions
The LC-TOF-MS method was validated, reliable, and suitable for the simultaneous detection and quantification of gatifloxacin, moxifloxacin, and besifloxacin concentrations in cornea and aqueous humor.
After 10 min and 1 h after instillation of topical suspensions in dogs, moxifloxacin was the fluoroquinolone that achieved the highest concentration in the cornea, whilst in the aqueous humor, it was besifloxacin. Both moxifloxacin and besifloxacin were present in cornea and aqueous humor at
Competing interests
The authors declare no competing interests.
Ethical approval
The experimental protocol used in this study was approved by the Ethics Committee in Animal Experimentation at the Universidade Federal de Minas Gerais-UFMG (protocol #266/2014) and by the Ethics Committee of the Center for Zoonosis Control of the Belo Horizonte city, Minas Gerais state, Brazil.
References (26)
- et al.
Determination of ofloxacin in human aqueous humour by high-performance liquid chromatography with fluorescence detection
Journal of Pharmaceutical and Biomedical Analysis
(1997) - et al.
Antibacterial action of quinolones: From target to network
European Journal of Medicinal Chemistry
(2013) - et al.
An adaptable HPLC method for the analysis of frequently used antibiotics in ocular samples
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
(2010) - et al.
Besifloxacin in the management of bacterial infections of the ocular surface
Canadian Journal of Ophthalmology
(2015) - et al.
Rapid, sensitive and selective HPLC-MS/MS method for the quantification of topically applied besifloxacin in rabbit plasma and ocular tissues: Application to a pharmacokinetic study
Journal of Pharmaceutical and Biomedical Analysis
(2016) - et al.
Rapid, sensitive and selective HPLC-MS/MS method for the quantification of topically applied besifloxacin in rabbit plasma and ocular tissues: Application to a pharmacokinetic study
Journal of Pharmaceutical and Biomedical Analysis
(2016) Ocular pharmacology and therapeutics
- et al.
Fourth generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics
American Journal of Ophthalmology
(2002) - et al.
Safety of moxifloxacin as shown in animal and in vitro studies
Survey of Ophthalmology
(2005) - et al.
Validation of chromatographic methods: Evaluation of detection and quantification limits in the determination of impurities in omeprazole
Journal of Chromatography. A
(2007)
Bloom A. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor
Ophthalmology
Mechanism of quinolone action and resistance
Biochemistry
HPLC method for the simultaneous analysis of fluoroquinolones and oxazolidinones in plasma
Journal of Chromatographic Science
Cited by (14)
A novel, sensitive, and widely accessible besifloxacin quantification method by HPLC-fluorescence: Application to an ocular pharmacokinetic study
2021, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life SciencesCitation Excerpt :LC-MS/MS has been applied in PK studies [7–9] for samples with a very low concentration (≤50 ng/mL). However, LC-QTOF/MS method [20] is still a less sensitive means of quantifying biological samples with a low drug concentration, and has a high lower limit of quantification (LLOQ, 420 ng/mL) resulting from its narrow linear ranges. Importantly, both LC-MS/MS and LC-QTOF/MS are not widely accessible because the approach is costly, requires specialized instrumentation with a unique set of expertise, and is associated with a prolonged learning curve. [22]
Liquid chromatography coupled to quadrupole time-of-flight mass spectrometry (QTOF/MS) assay for quantification of protodioscin in Brachiaria grasses
2018, ToxiconCitation Excerpt :Thus, in the present study, the chosen solvent for extraction of protodioscin from Brachiaria was acetonitrile:water (50:50), to avoid any transformation of the analyte. In order to validate the method, the accuracy, precision, and reproducibility of the LOD and LLOQ must be determined (Magnusson and Örnemark, 2014; Domingos et al., 2017). No interfering compound was observed at the same retention time of protodioscin in the selectivity evaluation.
Analysis of pharmaceuticals and small molecules in aqueous humor
2018, Journal of Pharmaceutical and Biomedical AnalysisCitation Excerpt :Endophthalmitis treatment or preoperative prevention usually include vancomycin to cover gram-positive organisms, and a cephalosporin (e.g. ceftazidime) or an aminoglycoside (e.g. amikacin) to cover gram-negative bacteria [42–44]. Analysis of research articles qualified for this review showed, that determination of antibiotics by separation techniques was performed mainly on human [41,46–62] and rabbit [10,39,63–71], but also on horse [72], dog [73], bovine [74], monkey [10], and hen [75,76] AH samples. Similarly to IOP-lowering drugs, in case of antibiotics liquid chromatography with MS [10,49,50,53,56,58–60,63,67–69,71,73,75,76] or UV [39,46,47,54,55,57,62,65,72,74] detection was the most often used.
Liquid chromatography–tandem mass spectrometry for rapid and selective simultaneous determination of fluoroquinolones level in human aqueous humor
2019, Journal of Pharmacological and Toxicological MethodsCitation Excerpt :The lowest sample volume reported in the literature was 50 μl of human aqueous humor and was used for the determination of moxifloxacin (Bucci Jr et al., 2016; Katz et al., 2005). A recent research reported the usage of aliquot of 500 μL of aqueous humor for the simultaneous determination of gatifloxacin, moxifloxacin, and besifloxacin (Domingos et al., 2017). Likewise, the LLOQ was reported at 40 ng/mL for ciprofloxacin (Bucci, 2004), 190 ng/mL for moxifloxacin (Bucci Jr et al., 2016), and 420 ng/mL for gatifloxacin and moxifloxacin (Domingos et al., 2017).